Matches in Wikidata for { <http://www.wikidata.org/entity/Q71649721> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q71649721 description "artículu científicu espublizáu en payares de 1982" @default.
- Q71649721 description "bài báo khoa học" @default.
- Q71649721 description "im November 1982 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71649721 description "scientific article published on 01 November 1982" @default.
- Q71649721 description "wetenschappelijk artikel" @default.
- Q71649721 description "наукова стаття, опублікована в листопаді 1982" @default.
- Q71649721 name "[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]" @default.
- Q71649721 name "[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]" @default.
- Q71649721 type Item @default.
- Q71649721 label "[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]" @default.
- Q71649721 label "[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]" @default.
- Q71649721 prefLabel "[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]" @default.
- Q71649721 prefLabel "[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]" @default.
- Q71649721 P1433 Q71649721-BC48787E-7CB2-411F-AD6F-A6642047E2F0 @default.
- Q71649721 P1476 Q71649721-4F40A67F-4046-4E17-9BA3-45047D5B23A7 @default.
- Q71649721 P2093 Q71649721-B6A6EC7C-17D5-4962-A506-0B9728851B52 @default.
- Q71649721 P304 Q71649721-BFBAD06A-94F5-4FCD-A2DE-50B57D1FC073 @default.
- Q71649721 P31 Q71649721-D8B7ADCF-DE3E-4EDB-9B12-436D41BC1308 @default.
- Q71649721 P433 Q71649721-328D6B17-14F9-49E9-817A-32B5CDC7288E @default.
- Q71649721 P478 Q71649721-5C531269-5391-4CFA-A898-6CD8CCCB9FF2 @default.
- Q71649721 P577 Q71649721-3770AC83-8003-4C94-858B-A99520CCDA78 @default.
- Q71649721 P698 Q71649721-5ABD6248-86AB-455F-84A5-BE162879E333 @default.
- Q71649721 P698 6821182 @default.
- Q71649721 P1433 Q27708722 @default.
- Q71649721 P1476 "[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs]" @default.
- Q71649721 P2093 "Yamada E" @default.
- Q71649721 P304 "269-287" @default.
- Q71649721 P31 Q13442814 @default.
- Q71649721 P433 "5" @default.
- Q71649721 P478 "52" @default.
- Q71649721 P577 "1982-11-01T00:00:00Z" @default.
- Q71649721 P698 "6821182" @default.